|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| C12N 9/64 | |||
| A61P 7/00 | |||
| A61P 7/04 |
| (11) | Patento numeris | 2453910 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10737699.8 |
| Europos patento paraiškos padavimo data | 2010-07-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-05-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/042015 |
| Data | 2010-07-14 |
| (87) | Numeris | WO 2011/008885 |
| Data | 2011-01-20 |
| (30) | Numeris | Data | Šalis |
| 225887 P | 2009-07-15 | US |
| (72) |
SINHA, Uma, US
LU, Genmin, US
HUTCHALEELAHA, Athiwat, US
HOLLENBACH, Stanley J., US
|
| (73) |
Portola Pharmaceuticals, Inc.,
270 East Grand Avenue Suite 22, South San Francisco California 94080,
US
|
| (54) | UNIT DOSE FORMULATION OF ANTIDOTE FOR FACTOR XA INHIBITORS FOR USE IN PREVENTING BLEEDING |
| UNIT DOSE FORMULATION OF ANTIDOTE FOR FACTOR XA INHIBITORS FOR USE IN PREVENTING BLEEDING |